Table 1 Baseline characteristics of morning-dose group and evening-dose group
Morning-dose group | Evening-dose group | P-value | |
|---|---|---|---|
Male | 57 | 49 | |
Female | 38 | 44 | 0.194a |
Age (years) | 62.1±13.6 (n=95) | 60.8±9.4 (n=93) | 0.451b |
Height (cm) | 161.1±10.6 (n=94) | 161.6±10.4 (n=93) | 0.795b |
Weight (kg) | 63.7±13.7 (n=95) | 63.8±14.4 (n=93) | 0.951b |
Abdominal circumference (cm) | 84.6±9.0 (n=94) | 83.9±10.7 (n=89) | 0.611b |
BMI (kg m−2) | 24.4±3.6 (n=94) | 24.3±3.9 (n=93) | 0.834b |
LDL-cholesterol (mg dl−1) | 127.8±28.6 (n=90) | 124.8±35.3 (n=90) | 0.520b |
HDL-cholesterol (mg dl−1) | 63.0±16.6 (n=94) | 62.1±14.6 (n=93) | 0.694b |
Triglycerides (mg dl−1) | 156.4±107.9 (n=95) | 136.0±86.3 (n=93) | 0.156b |
Creatinine (mg dl−1) | 0.79±0.55 (n=95) | 0.71±0.17 (n=93) | 0.204b |
Na (mequiv. l−1) | 141.5±2.0 (n=94) | 141.2±2.0 (n=92) | 0.366b |
K (mequiv. l−1) | 4.3±0.7 (n=94) | 4.2±0.5 (n=93) | 0.379b |
Cl (mequiv. l−1) | 103.4±2.3 (n=93) | 103.4±2.6 (n=93) | 0.953b |
Fasting plasma glucose (mg dl−1) | 107.2±23.7 (n=92) | 108.9±42.3 (n=92) | 0.733b |
HbA1c (%) | 5.3±0.6 (n=93) | 5.5±1.1 (n=90) | 0.196b |
Administration of diabetic medicines | 9.5% (n=95) | 8.6% (n=93) | 0.519a |
Percentage of CKD | 6.3% (n=95) | 6.5% (n=93) | 0.602a |
